Literature DB >> 18241779

The encephalopathy in sepsis.

Shidasp Siami1, Djillali Annane, Tarek Sharshar.   

Abstract

Brain dysfunction is a severe complication of sepsis with an incidence ranging from 9% to 71% that is associated with increased morbidity and mortality. Its diagnosis relies mainly on neurologic examination with clinical manifestations ranging from confusion to coma. An electroencephalogram, somatosensory evoked potentials, and measurement of plasma S-100b protein and neuron-specific enolase can be useful for the detection of brain dysfunction. Brain MRI can identify brain lesions such as cerebral infarction, posterior reversible encephalopathy syndrome, and leukoencephalopathy. The mechanism of sepsis-associated encephalopathy involves inflammatory and non-inflammatory processes that affect endothelial cells, glial cells, and neurons and induce blood-brain barrier breakdown, derangements of intracellular metabolism, and cell death. Specific treatments for sepsis-associated encephalopathy need to be developed. Currently, treatment is mainly the management of sepsis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241779     DOI: 10.1016/j.ccc.2007.10.001

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  33 in total

1.  A Systematic Review and Meta-Analysis Examining the Impact of Sleep Disturbance on Postoperative Delirium.

Authors:  Ayòtúndé B Fadayomi; Reine Ibala; Federico Bilotta; Michael B Westover; Oluwaseun Akeju
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

Review 2.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

3.  Does prior sepsis alter subsequent circadian and sickness behaviour response to lipopolysaccharide treatment in mice?

Authors:  Sean T Anderson; Emma K O'Callaghan; Sean Commins; Andrew N Coogan
Journal:  J Neural Transm (Vienna)       Date:  2013-12-15       Impact factor: 3.575

4.  Effects of hydrogen sulfide on a rat model of sepsis-associated encephalopathy.

Authors:  Di Chen; Hao Pan; Chunwen Li; Xiucai Lan; Beibei Liu; Guangtian Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

5.  Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Sebastian Weckbach; Markus Huber-Lang; Kyros Ipaktchi; Peter A Ward; Philip F Stahel
Journal:  Ann Intensive Care       Date:  2011-12-30       Impact factor: 6.925

6.  The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis.

Authors:  Guo-Bin Wang; Yun-Lan Ni; Xin-Ping Zhou; Wei-Fang Zhang
Journal:  Mol Cell Biochem       Date:  2013-09-22       Impact factor: 3.396

7.  Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

Authors:  Li-Ming Wang; Qi Wu; Ryan A Kirk; Kevin P Horn; Ahmed H Ebada Salem; John M Hoffman; Jeffrey T Yap; Joshua A Sonnen; Rheal A Towner; Fernando A Bozza; Rosana S Rodrigues; Kathryn A Morton
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

Review 8.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

Review 9.  Cerebral perfusion in sepsis.

Authors:  Christoph S Burkhart; Martin Siegemund; Luzius A Steiner
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

10.  Mechanisms of brain signaling during sepsis.

Authors:  Najla Akrout; Tarek Sharshar; Djillali Annane
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.